FDA to pull common but ineffective cold medicine from market
The Food and Drug Administration announced Wednesday that it would seek to pull a widely used ingredient in cough and cold medicines from the market, after the agency's scientists concluded that the oral version of the drug is ineffective as a nasal decongestant.
FDA Wants to Ban Popular But Ineffective Cold Remedy Ingredient
The agency made the proposal after finding that the ingredient, known as oral phenylephrine, doesn’t relieve stuffy noses.
FDA proposes removing ineffective decongestant found in most cold medicine
The Food and Drug Administration (FDA) is proposing the removal from the market of a common ingredient found in most oral over-the-counter cold medicines because it doesn’t work.
FDA Agrees Ingredient in Cold Medicines Doesn't Work
After what the agency called a thorough review of the data, the Food and Drug Administration has proposed ending the use of an ingredient of many cold and allergy medications because it doesn't work.
FDA proposes removing popular decongestant found in cold meds
The Food and Drug Administration (FDA) is proposing to officially remove a popular ingredient in many cold and allergy medications – oral phenylephrine.
The FDA wants to ban a common ingredient in over-the-counter cold and allergy medications
The U.S. Food and Drug Administration (FDA) announced today that it is proposing a new rule to stop the use of an ingredient in popular over-the-counter cold and allergy medications.
Myrtle Beach's Market Common will add townhomes and a coffee shop. Not everyone is happy about it.
Despite neighbors' objections, a drive-thru coffee shop, rental townhomes and cottages got the go-ahead to be built in Myrtle ...
Daily Voice Windham County CT on MSN17m
These Over-The-Counter Decongestants Don't Work, FDA Says
A common ingredient found in most oral over-the-counter cold medicines should be removed from the market because it doesn’t ...
Luxury Estate Built on Site of Infamous 'Mansion Murders' Property Hits the Market for $8.5 Million—9 Years After Horrifying Killings
An incredibly modern mansion that was built on the site of the infamous "Mansion Murders" home has hit the market for $8.5 ...
Sonnet BioTherapeutics Announces Pricing of $5.0 Million Underwritten Public Offering Priced At-The-Market Under Nasdaq Rules
Sonnet BioTherapeutics Holdings, Inc. (the "Company" or "Sonnet”) (NASDAQ: SONN), a clinical-stage company developing ...
Mises Institute7h
The Limits to Public Opinion and the Failure of Democracy
The question of restricting democracy came up because people tend to vote in ways that are contrary to their own interests in ...
‘Kia Sorento… Probably the worst motors ever made’: Expert reveals the 5 worst mid-size SUVs that will cost you tons in repairs
TikTok creator Bev (@bevurly) is out to save people from what he calls “junk” vehicles. In one of his latest TikTok videos, ...
Traders Magazine20h
Who Pays for Innovation? Why Market Collaboration is the Key to More Connectivity
The market needs more agility and connectivity to manage greater volumes and demands. But the question of who takes ownership for this innovation – and bears the cost – is more complex. With more ...
The Election 2024 Playbook
Potential outcomes for the S&P500 post-election, include relief rally or crash scenarios due to election uncertainty and ...
Mortgage-backed securities: How they impact the housing market and interest rates
Mortgage-backed securities (MBS) are a type of investment. Learn more about what MBS are, as well as how they impact the ...
New Antibiotic Hits the Market to Tackle Stubborn UTIs
The Food and Drug Administration has approved Iterum Therapeutics' Orlynvah, the first drug of its kind, which is designed to ...
The Stock Market Is Doing Something It Hasn't Done in Over a Half-Century, and It Could Signal a Big Move in 2025
In September, the Fed made its first interest rate cut since 2020, and it could be the start of a long cutting cycle over the ...